Survival rates for bone cancer indicate the chances of survival after the diagnosis of a particular type of bone cancer. It is normally considered along with the duration of a specific stage of the cancerous growth. The statistical data is at best a relative case study and survival cannot be successfully predicated on probabilities.
5 years are usually taken as a measure since the time of diagnosis for survival rates in bone cancer. The stage at which the cancer has progressed determines the period of survival thereafter but it befits the patient to not be influenced by pure data and consider the period since the symptoms existed and a possible period of silent growth while the patient appeared perfectly healthy. Also, the quality of treatment available along with overall health, stress levels and genetic predisposition would greatly influence the life expectancy. [Read: How Long Can a Person Live With Bone Cancer?]
In recent studies, the survival rates show that more than 80% live for 5 years if they are diagnosed at the earliest stage when the cancer is still localised at its point of origin and has not spread. The second stage in which cancer has increased but has not involved organs or lymph nodes shows a 70% rate. When in the third stage, cancer spreads to the surrounding lymph nodes the rate may fall upto 60%.
In the last stage, when the patient has stopped responding to the treatment considerably and cancer has spread to organs, the survival rate may vary from 20 to 50%. Although, the definition of ‘terminal’ may be somewhat slippery as it can even denote a longer period involving many months left in a patient’s lifetime rather than a few hours or days as one might suspect. [Read: Bone Cancer Life Expectancy]
Another point to be kept in mind is that about 40% of cases are diagnosed early in the primary stage so a significant number of patients are hopeful of surviving for years with a normal lifestyle. On the other hand, around 15% of patients are diagnosed when they have reached the terminal stage. Interestingly, in the case of slow growing bone cancers the chances of a longer survival increase.
As a side note, data on age should also be looked at. About 30% of bone cancer diagnoses are made in teenagers and about 8% in sexagenarians. Moreover, patients suffering from Chondrasarcoma have the slight benefit of 80% 5 year survival rate over Ewing Sarcoma and Osteosarcoma which are nearly 70%. [Read: Life Expectancy with Bone Marrow Cancer]
Life expectancy may differ from patient to patient but the decision to administer medication in the hope of any improvement rests with the doctor. It may or may not prolong life with a reasonable respite from suffering. Hope however, floats.
-1751527287915.png)
-1751352905978.jpg)
